ArticleFrontiers in oncology2025

Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy.

Danhong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.